The crew met with Brent Owens, Co-Founder & Deputy CEO of Vitrafy, in downtown Melbourne to explore the critical role of cryopreservation in biopharma. Vitrafy offers a vertically integrated solution that ensures the quality and safety of cryopreserved biomaterials, particularly for cell and gene therapies. As the industry sees a surge in CAR-T therapies requiring specialized storage, Brent discusses how Vitrafy’s focus on biopreservation fortifies the supply chain, ensuring that life-saving treatments reach patients safely and effectively.
